Results 111 to 120 of about 581,626 (194)
Background Transcatheter aortic valve implantation has become an accepted treatment modality for inoperable or high-risk surgical patients with symptomatic severe aortic stenosis.
Shahram Lotfi +5 more
doaj +1 more source
Same‐Day Discharge After Transcatheter Aortic Valve Implantation: Who, When, and How?
ABSTRACT The burden of severe aortic stenosis requiring treatment is growing due to ageing populations. This places increased demands on health resources due to the growing number of transcatheter aortic valve implantation (TAVI) procedures and hospital bed occupancy.
Hilal Khan +8 more
wiley +1 more source
Transapical valve-in-valve implantation for regurgitant stented aortic bioprostheses
Transcatheter aortic valve implantation (TAVI) is rapidly evolving as an alternative treatment option for elderly patients with severe symptomatic aortic stenosis and excessive risk for surgical intervention.
Windecker, Stephan +5 more
core
Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation [PDF]
This study sought to assess the impact of permanent pacemaker (PPM) implantation on clinical outcomes among patients undergoing transfemoral transcatheter aortic valve implantation (TAVI)
Heg, Dik +19 more
core +2 more sources
ABSTRACT Background Pulmonary valve replacement is frequently required in adults with congenital heart disease (CHD). Comparative real‐world outcomes between percutaneous transcatheter pulmonary valve implantation (TPVR) and surgical pulmonary valve replacement (SPVR) remain incompletely characterized. We evaluated outcomes and resource utilization for
Adam Bolad +4 more
wiley +1 more source
Latest evidence on transcatheter aortic valve implantation vs. surgical aortic valve replacement for the treatment of aortic stenosis in high and intermediate-risk patients. [PDF]
PURPOSE OF REVIEW The goal of this review is to summarize the current evidence supporting the use of transcatheter aortic valve implantation (TAVI) in high and intermediate-risk patients. The focus is on the five randomized controlled trials comparing
Windecker, Stephan +4 more
core +1 more source
TAVI Using a Self-Expandable Device for Aortic Regurgitation Following LVAD Implantation
Background In patients treated by left ventricular assist device (LVAD), aortic regurgitation (AR) may occur. Secondary surgery to correct AR is considered high risk.
Harun Sarwari +3 more
doaj +1 more source
ABSTRACT Severe aortic stenosis (AS) carries a poor prognosis when symptomatic, particularly in cardiogenic shock (CS). Emergency transcatheter aortic valve replacement (TAVR) is rarely performed but may represent a rescue therapy. Coexistent carotid artery stenosis (CAS) further increases procedural risk.
Max Groche +3 more
wiley +1 more source
Failed Valve-In-Valve Transcatheter Aortic Valve Implantation
In 2004, a 68-year-old man received aortocoronary bypass surgery and a 23-mm Hancock porcine bioprosthesis (Medtronic, Minneapolis, Minnesota). Six years later, in January 2011, cardiac re-evaluation was performed due to progressive dyspnea.
Klotz, Stefan +3 more
openaire +2 more sources
ABSTRACT Hypo‐attenuated leaflet thickening (HALT) is an important and potentially underrecognized cause of late bioprosthetic valve dysfunction after surgical AVR. Multimodal imaging, including echocardiography and electrocardiogram‐gated computed tomography, is essential for diagnosis, and timely surgical or medical intervention can effectively ...
Takanori Kono +4 more
wiley +1 more source

